Bristol-Myers Squibb Co. Chief Executive Giovanni Caforio is planning to retire, the company said Wednesday. Chief Commercialization Officer Christopher Boerner will take the helm when Dr. Caforio leaves Nov.
1, the company said. Dr. Caforio will remain executive chairman of the drugmaker.We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: